Company: G
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001398659-25-000109
Chunk: 177

Company: Genpact LTD
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 8
Chunk 177
---
 volatility for the companies in the Peer Group was measured using the most recent three-year period.•The risk-free interest rate is based on the U.S. Treasury rate assumption commensurate with the three-year performance period.•For determining the TSR of the Company and the companies in the Peer Group, dividends are assumed to have been reinvested in the stock of the issuing entities on a continuous basis.•The correlation coefficients used to model the way in which each entity tends to move in relation to each other are based upon the price data used to calculate historical volatility.The fair value of each PU granted to employees in the nine months ended September 30, 2024 and September 30, 2025 was estimated on the date of grant using the following valuation assumptions:Nine months ended September 30, 2024Nine months ended September 30, 2025Dividend yield1.62 %— 1.81 %1.37%Expected life (years)2.38— 2.802.81Risk-free rate for expected life 3.83 %— 4.37 %3.89%Volatility for expected life 24.24 %— 26.33 %25.78%A summary of PU activity during the nine months ended September 30, 2025 is set out below: Nine months ended September 30, 2025Number of Performance UnitsWeighted Average Grant Date Fair ValueMaximum Shares Eligible to ReceiveOutstanding as of January 1, 20253,257,804 $39.77 6,204,877Granted874,139 53.922,097,934Vested (Note a)(1,154,998)44.50(1,154,998)Forfeited(290,064)39.45(696,154)Outstanding as of September 30, 20252,686,881 42.386,451,659Expected to vest (Note b)2,755,910   (a)1,154,998 PUs vested during the nine months ended September 30, 2025, in respect of which 738,490 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2025.(b)The number of PUs expected to vest is based on the probable achievement of the performance targets after considering an estimated forfeiture rate.

38

GENPACT LIMITED AND ITS SUB